Ibex Medical Analytics Appoints Yair Heller as Chief Executive Officer
PRIVATEFeb 18, 2026
Position
Chief Operating Officer
Company
Ibex Medical Analytics
Joseph Mossel
Tel AvivInformation TechnologyBiotechnologySoftwareHealth CareArtificial IntelligenceMachine LearningHealth Diagnostics
Description
Ibex Medical Analytics announces the appointment of Yair Heller as Chief Executive Officer effective immediately. Co-founder Joseph Mossel will now lead the company's biopharma division and U.S. clinical growth initiatives.
Company Information
Company
Ibex Medical Analytics
Location
Tel Aviv, Tel Aviv District, Israel
About
Ibex Medical Analytics pioneers AI-based cancer diagnostics in pathology.
Pathologists are challenged to provide accurate and timely cancer diagnoses as their workloads keep increasing due to a rise in cancer prevalence and advances in personalized medicine that result in growing diagnostic complexity.
We use artificial intelligence (AI) to develop clinical-grade algorithms and digital workflows that detect cancer as accurately as a human pathologist.
Our Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers eliminate diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.
Deployed worldwide, Galen is the first-ever AI-powered cancer diagnostics platform used in routine clinical practice in pathology labs, with demonstrated success in improving the quality and efficiency of cancer diagnosis.
We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision: transform cancer diagnosis with AI and improve patient care.
If you are an outstanding professional constantly looking for challenges, passionate about your work, a team player and want to make real impact – we want to hear from you.
Fundz sees it the moment Ibex Medical Analytics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.